ProMIS Neurosciences, Inc. (PMN)

NCM – Real vaqt narxi. Valyuta: USD

14.68

-0.29 (-1.94%)

Bozor ochiq: Aug 12, 2026, 12:52 PM EDT

14.41

-0.56 (-3.74%)

Oldingi bozordan keyin: Aug 11, 2026, 5:12 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

03.08.2026

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026.

Videolar

No Data

There is no data to display

ProMIS Neurosciences, Inc. (PMN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videolar

No Data

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videolar

No Data

Search stocks

ProMIS Neurosciences, Inc. (PMN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videolar

No Data

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videolar

No Data